Skip to main content
Log in

Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin

A preliminary study

  • Part III Cancer and Immunity
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Adriamycin is a potent chemotherapeutic agent used in the treatment of human neoplastic diseases. A major side effect limiting the use of this drug is its toxic effect on the heart. Several hypotheses have been proposed to explain the cardiotoxicity of Adriamycin. However, the most plausible hypothesis seems to be the reduction of Adriamycin and free radical production, which induces lipid peroxidation and oxidative damages in the heart.

We have thus undertaken this preliminary study to investigate Adriamycin-induced lipid peroxidation by the measurement of plasma thiobarbituric acid reactant materials and antioxidant systems, namely glutathione content, glutathione peroxidase activity, and vitamin and trace element status, in patients with cancer before and after chemotherapy, including Adriamycin.

The concentration of thiobarbituric acid reactant materials in plasma of patients with cancer was higher than in controls and was further increased after chemotherapy. Blood glutathione and plasma glutathione peroxidase activity, as well as plasma zinc and selenium in patients with cancer, were decreased, but not further modified by chemotherapy. However, only zinc and selenium levels reached a significant level. In contrast, plasma vitamin E and β-carotene levels were not significantly increased in patients with cancer. Finally, plasma vitamin A and copper levels were not modified either in patients with cancer or by chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADR:

Adriamycin

GSH:

reduced glutathione

GSSG:

oxidized glutathione

GPx:

glutathione peroxidase

OHP:

organic hydroperoxides

TBARMs:

thiobarbituric acid reactant materials

References

  1. R. C. Young, R. E. Ozols, and C. E. MeyersN. Engl. J. Med. 305, 139 (1981).

    Article  PubMed  CAS  Google Scholar 

  2. R. E. Ozols, R. C. Young, and J. L. SpeyerCancer Res. 42, 4265 (1982).

    PubMed  CAS  Google Scholar 

  3. S. Ragajopalan, P. M. Politi, B. Sinha, and C. E. MeyersCancer Res. 48, 4766 (1988).

    Google Scholar 

  4. R. D. Olson, R. C. Boerth, J. G. Gerber, and A. S. NiesLife Sci. 29, 1393 (1981).

    Article  PubMed  CAS  Google Scholar 

  5. C. Winterbourn, G. F. Vile, and H. P. MonteiroFree Radic. Res. Commun. 12–13, 107 (1991).

    PubMed  Google Scholar 

  6. K. Hermann, and S. HelmutExperientia 37, 1233 (1981).

    Article  Google Scholar 

  7. K. Takahashi, T. Mayumi, and T. KishiChem. Pharm. Bull. 35, 4626 (1978).

    Google Scholar 

  8. J. C. Schisselbauer, M. Crescimanno, N. D’Alessandro, M. Clapper, S. Toulmond, H. Tapiero, and K. D. TewCancer Commun. 1, 133 (1989).

    PubMed  CAS  Google Scholar 

  9. M. J. Richard, B. Portal, J. Meo, C. Coudray, A. Hadjian, and A. FavierClin. Chem. 38, 704 (1992).

    PubMed  CAS  Google Scholar 

  10. R. L. Heath, and A. L. TappelAnal. Biochem. 76, 184 (1976).

    Article  PubMed  CAS  Google Scholar 

  11. W. A. Günzler, H. Kremers, and L. FloheZ. Klin. Chem. Klin. Biochem 10, 444 (1974).

    Google Scholar 

  12. T. P. M. Akerboom, and H. SiesMethods Enzymol. 77, 373 (1981).

    PubMed  CAS  Google Scholar 

  13. J. Arnaud, S. Fortis, S. Blachier, D. Kia, and A. FavierJ. Chromatogr. 572, 103 (1991).

    Article  PubMed  CAS  Google Scholar 

  14. J. Arnaud, J. Bellanger, P. Chappuis, A. Favier, and M. GalliotAnn. Biol. Clin. 43, 297 (1985).

    Google Scholar 

  15. J. Arnaud, J. Bellanger, F. Bienvenu, P. Chappuis, and A. FavierAnn. Biol. Clin. 44, 77 (1986).

    CAS  Google Scholar 

  16. J. Arnaud, A. Prual, P. Preziosi, A. Favier, and S. HercbergJ. Trace Element Electrolytes Health Dis. 7, 199–204 (1993).

    CAS  Google Scholar 

  17. E. A. Lefrak, J. Pitha, S. Rosenheim, and J. A. GottliebCancer 32, 302 (1973).

    Article  PubMed  CAS  Google Scholar 

  18. R. A. Minow, R. S. Benjamin, and J. A. GottliebCancer Chemotherapy Rep. 6, 195 (1975).

    Google Scholar 

  19. S. NeidelProg. Med. Chem. 16, 151 (1979).

    Article  Google Scholar 

  20. U. Montali, M. Del Tacca, C. Bernardini, D. Segnini, and G. Solaini,Drugs Explt. Clin. Res. 11, 219 (1985).

    CAS  Google Scholar 

  21. R. G. Canada, W. Saway, and E. ThompsonBiochem. Biophys. Res. Commun. 151, 679 (1988).

    Article  PubMed  CAS  Google Scholar 

  22. K. J. A. Davis, and J. H. DoroshowJ. Biol. Chem. 261, 3060 (1986).

    Google Scholar 

  23. H. NohlBiochem. Pharmacol. 37, 2633 (1988).

    Article  PubMed  CAS  Google Scholar 

  24. G. PowisFree Radical Biol. Med. 6, 63 (1989).

    Article  CAS  Google Scholar 

  25. H. Hida, C. Coudray, J. Calop, and A. Favier,Biol Trace Element Res. accepted for publication (1994).

  26. C. Coudray, S. Mouhiedine, M. J. Richard, J. Arnaud, J. de Leiris, and A. FavierBasic Res. Cardiol. 87, 173 (1992).

    Article  PubMed  CAS  Google Scholar 

  27. P. Sangeetha, U. N. Das, R. Koratkar, and P. SuriyaprabhaFree Radic Biol. Med. 8, 19 (1990).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faber, M., Coudray, C., Hida, H. et al. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. Biol Trace Elem Res 47, 117–123 (1995). https://doi.org/10.1007/BF02790108

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02790108

Index Entries

Navigation